NCT00514787已完成不适用
Be SMART NIS, Moderate to Servere Asthma Patient Observation
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 900
- 试验地点
- 1
研究概览
简要总结
Screen for moderate to severe asthma patients with suboptimal asthma control (as defined by GINA-Guidelines). Document current asthma control status. Re-evaluate asthma therapy and document new therapy if applicable.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Moderate to severe asthma with suboptimal control
排除标准
- •Intermittent or mild asthma, patient with good asthma control
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Evaluation of the Control Level of Asthmatic Patients With Seasonal Increase of Respiratory Symptoms (High and/or Low)Respiratory SymptomsAsthmaNCT00882128AstraZeneca3,300
终止
4 期
Management of Asthma Patients Guided by Exhaled Nitric Oxide (eNO)AsthmaNCT00739219Apieron260
尚未招募
不适用
Clinical Study of Lung-benefiting Moxibustion Reduce Exacerbations of AsthmaAsthmaNCT06777472Cuiling Feng384
已完成
不适用
The Severity of Newly Diagnosed Asthma Patients and the Result of Initial 12 Weeks Treatment in ChinaAsthmaNCT02143739AstraZeneca4,817
进行中（未招募）
不适用
To test if higher doses of ciclesonide bring a better control of asthmamoderate or severe asthmaMedDRA version: 17.0Level: PTClassification code 10003553Term: AsthmaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2011-000683-99-DETakeda Development Centre Europe Ltd.360